NewAmsterdam Pharma Company N.V. is a Dutch biotechnology company focused on the development of innovative therapeutic drugs for the treatment of cardiometabolic and liver diseases. The company specializes in research and development of drugs that target specific biological pathways related to these conditions, including treatments for high cholesterol, liver cirrhosis, and other chronic diseases. NewAmsterdam Pharma focuses on providing effective therapeutic options that can improve the health of patients suffering from these complex diseases.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
